Navigation Links
Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
Date:12/8/2009

WELLESLEY HILLS, Mass., Dec. 8 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. Managing Partner of Finn, Warnke & Gayton announced today that the firm is offering a sales platform for biotechnology companies to sell their intellectual property. According to industry sources, many of these enterprises have intellectual property sitting dormant in various stages of development due to funding, scientific or regulatory issues.

Finn noted that the firm's experience in selling the intellectual property of ActivBiotics, Spherics, Prospect Therapeutics, Alpha Beta Technologies and Epix Pharmaceuticals has given it the opportunity to develop a database of active buyers and create a legal platform to conduct sales. It has also created a steady flow of inquires from biotech firms and individuals regarding the firm's future offerings of intellectual property.

Persons interested in discussing this service should contact Joseph F. Finn, Jr., Christopher J. Finn, or Paul Bolger at 781-237-8840 or Link';s.eVar3=s.prop5;s.prop15='78779862';s.tl(this,'o','ExternalLink');">jffinnjr@earthlink.net.

About Finn, Warnke & Gayton

For over 35 years, Finn, Warnke & Gayton has been one of the region's most respected business consulting and accounting firms. In addition to our new service, our team of professionals provides management consulting services to distressed enterprises, accounting, trustee, and agency services related to bankruptcy and insolvency matters, advisory services to financial institutions, interim management, and traditional tax and accounting services to corporations and individuals. For more information on the firm, please visit our website at Link';s.eVar3=s.prop5;s.prop15='78779862';s.tl(this,'o','ExternalLink');">finnwarnkegayton.com.

SOURCE Finn, Warnke & Gayton


'/>"/>
SOURCE Finn, Warnke & Gayton
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A.
2. Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
3. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
4. SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles
5. SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles
6. Polymathic Analytical Labs Debuts at World's Largest Medical Design & Manufacturing Exhibition
7. M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks
8. Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
9. Ovalum Ltd. Received Clearance to Market the CiTop™ Product-Line in Israel
10. Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire
11. Argonne researchers win 2 R&D 100 Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - http://photos.prnewswire.com/prnh/20160524/371420 ... ... ... With ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
Breaking Biology News(10 mins):